Document:

Offer Letter

 EXHIBIT 10.1 
 April 17, 2009 
 Ms. Karen Wilson 
 Dear
Karen: 
 On behalf of PDL BioPharma, Inc. (‘PDL’ or ‘we’), I am pleased to extend to you an employment offer for the position of Vice
President of Finance and Principal Accounting Officer reporting to PDL’s Chief Financial Officer (the ‘CFO’). Your employment with PDL will begin on April 22, 2009 (the ‘Employment Date’). 
 You agree that you will devote your full business time and efforts to PDL. You agree that you will not engage in any other business or serve in any position with or as a
consultant or adviser to any other corporation or entity (including as a member of such corporation’s or entity’s board of directors or other governing or advising body), without the prior written consent of the Board. Notwithstanding the
foregoing, but only for so long as such activities in the aggregate do not materially interfere with your duties hereunder or create a business or fiduciary conflict, you will not be prohibited from (i) participating in charitable, civic,
educational, professional, community or industry affairs (including membership on boards of directors), (ii) managing your passive personal investments, and (iii) continuing your service in the positions that you held as of the date of
this Offer Letter, which positions you have disclosed to the Board, provided that any such service obligation is not materially increased beyond what you have disclosed to us. 
 Your base salary (as in effect from time to time, ‘Base Salary’) will be $250,000 annually, less applicable taxes and withholdings, and will be payable in accordance PDL’s payroll procedures. Your
annual target bonus will be set at thirty-five percent (35%) of your annual Base Salary. Your bonus will be based on your contribution to PDL’s achievement of its goals and objectives and your individual performance during this period as
determined by the CFO and the Compensation Committee of the Board. 
 Effective fifteen (15) days following the Employment Date, PDL will grant you a
special retention incentive award (the ‘Special Retention Incentive’) comprising two components: (i) the right to receive $175,000 in cash; and (ii) a number of unvested restricted shares of PDL common stock with a Grant Value
equal to $75,000. For this purpose, ‘Grant Value’ means the average of the closing prices of PDL’s common stock for the first ten (10) trading days following the Employment Date. Subject to your continued employment, the Special
Retention Incentive will vest and become payable upon the earlier to occur of (i) December 19, 2010, or (ii) a Monetization Event. For purposes of this Offer Letter, ‘Monetization Event’ means (i) a merger or sale of
PDL or a sale of all or substantially all of PDL’s assets, or (ii) any securitization or other monetization of all or substantially all of PDL’s assets. In the event any dividends or other distributions are paid on PDL’s common
stock following the grant of the Special Retention Incentive but prior to the vesting and payment thereof, the amount of the dividends or other distributions payable on the restricted stock component of the Special Retention Incentive shall be
withheld, credited to an account in your name, and shall vest and become payable if and when the Special Retention Incentive vests and becomes payable. 

 If you are terminated without Cause or resign for Good Reason, but prior to your entitlement to the Special Retention
Incentive, you will receive, a lump sum cash payment equal to twenty-five percent (25%) of the sum of your annual base salary and target bonus provided that such payment shall be contingent upon your signing a release of all claims against PDL.

 For purposes of this Offer Letter, ‘Cause’ means the occurrence of any of the following: (i) your intentional theft, dishonesty, willful
misconduct, breach of fiduciary duty for personal profit, or falsification of any PDL documents or records; (ii) your material failure to abide by the PDL’s code of conduct or other written policies (including, without limitation, policies
relating to confidentiality and reasonable workplace conduct); (iii) your material and intentional unauthorized use, misappropriation, destruction or diversion of any tangible or intangible asset or corporate opportunity of PDL (including,
without limitation, your improper use or disclosure of PDL confidential or proprietary information); (iv) any willful act by you that has a material detrimental effect on PDL’s reputation or business; (v) your repeated failure or
inability to perform any reasonable assigned duties after written notice from the CFO of, and a reasonable opportunity to cure, such failure or inability; (vi) any material breach by you of any employment, service, non-disclosure,
non-competition, non-solicitation or other similar agreement between you and PDL, which breach is not cured pursuant to the terms of such agreement or within twenty (20) days of receiving written notice of such breach; (vii) your
conviction (including any plea of guilty or nolo contendere) of any criminal act involving fraud, dishonesty, misappropriation or moral turpitude, or which impairs your ability to perform your duties with PDL. For purposes of the foregoing, no act
or omission will be deemed ‘willful’ unless done, or omitted to be done, by you without a reasonable good faith belief that you were acting in the best interest of PDL. 
 For purposes of this Offer Letter, ‘Good Reason’ means the occurrence of any of the following conditions without your informed written consent: (i) a material diminution in your authority, duties or
responsibilities, causing your position to be of materially lesser rank or responsibility within PDL; (ii) a requirement that you report to a corporate officer or other employee rather than directly to the CFO; (iii) a material reduction
in your Base Salary or bonus, unless reductions comparable in amount and duration are concurrently made for all other PDL officers; or (iv) any action or inaction by a PDL that constitutes, with respect to the you, a material breach of this
Offer Letter. 
 PDL has a welfare benefits package, including a comprehensive medical policy and dental plan, as well as life insurance coverage, in which
you will be eligible to participate in accordance with PDL guidelines. 
 Because PDL is re-domiciling PDL in Nevada and because of the difficulties in
selling a home in the Bay Area at an acceptable price, PDL will provide assistance to you to rent housing in Nevada proximate to PDL’s offices. PDL will pay you a housing allowance of $3,500 per month for one year from the Employment Date and
PDL agrees to consider extending such assistance prior to the first anniversary date of the Employment Date. In addition, to defray your moving expenses, PDL will reimburse you for such expenses up to $5,000. 

 Your employment with PDL will not be for a set term, and you will be an at-will employee. As a PDL employee, you will be
free to resign at any time, just as we will be free to terminate your employment at any time, with or without Cause. There will be no express or implied agreements to the contrary. By signing this Offer Letter, you agree to waive any right to
participate in the PDL Executive Retention and Severance Plan or any other severance plan maintained by PDL from time to time. 
 PDL intends that payments
and benefits provided to you pursuant to this Offer Letter be exempt from or comply with all applicable requirements of Section 409A of the Internal Revenue Code of 1986, as amended. Any ambiguities in this Offer Letter shall be construed in a
manner consistent with such intent. 
 For purposes of federal immigration law, you will be required to provide PDL documentary evidence of your identity and
eligibility for employment in the United States. 
 To indicate your acceptance of our offer, please sign and date this Offer Letter in the space provided
below and return it, along with a signed copy of the enclosed Proprietary Information and Invention Assignment Agreement, to Christine Larson. By executing this Offer Letter, you hereby represent that your execution hereof and performance of your
obligations hereunder do not and will not contravene or otherwise conflict with any other agreement to which you are a party or any other legal obligation applicable to you. This Offer Letter, along with the Proprietary Information and Invention
Assignment Agreement, supersedes any prior representations or agreements, whether written or oral, with respect to our offer of employment to you. This Offer Letter may not be modified or amended except by a written agreement, signed by PDL and you.

 We are very excited at the prospect of your joining PDL. 
  

					
	Sincerely,	 		 	
			
	PDL BioPharma, Inc.	 		 	Accepted by:
			
	/s/ Christine Larson	 		 	/s/ Karen Wilson
	Christine Larson	 		 	Karen Wilson
	Vice President & CFO	 		 	Date: April 22, 2009
	PDL BioPharma, Inc.Amendment Number 1 to the Penn Virginia Corporation

 Exhibit 10.2 
 PENN VIRGINIA CORPORATION 
 AMENDMENT NUMBER 1 TO THE 
 SIXTH AMENDED AND RESTATED 
 1999 EMPLOYEE STOCK INCENTIVE PLAN 
 This Amendment Number 1 to the Sixth Amended and Restated 1999 Employee Stock
Incentive Plan (the “Amendment”) is effective immediately upon the approval by the shareholders of Penn Virginia Corporation (the “Company”) of the Sixth Amended and Restated 1999 Employee Stock Incentive Plan (the
“Plan”). 
 Whereas, the Company is setting forth in this Amendment changes to the Plan to limit the grants of shares and
restricted stock available under the Plan; 
 Now, therefore, the Company amends the Plan in the following respects: 
 Section 4 of the Plan is hereby amended in its entirety to read as follows: 
 “4. Stock Subject to Plan 
 Subject to Section 13, not more than 6,335,000 Shares in the aggregate may be issued pursuant to the Plan and of the foregoing 6,335,000 Shares, no more than 350,000 Shares in the aggregate may be issued as Restricted Stock Awards or
pursuant to Restricted Stock Unit Awards. For purposes of determining the number of Shares issued under the Plan, no Shares shall be deemed issued until they are actually delivered to a Participant, Optionee or any other person in accordance with
Section 8(b). Shares covered by Options, Restricted Stock Awards or Restricted Stock Unit Awards that either wholly or in part expire or are forfeited or terminated shall be available for future issuance under the Plan. Any Shares tendered to
or withheld by the Company in connection with the exercise of Options, or the payment of tax withholding on any Option, Restricted Stock Award or Restricted Stock Unit Award shall not be available for future issuance under the Plan.”

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00157-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00157-of-00352.parquet"}]]